5 Amino 1MQ 50MG
$400.00
5 Amino 1MQ 50MG is a 50-milligram format of 5-amino-1-methylquinolinium (5-amino-1MQ), a small-molecule compound studied as an NNMT inhibitor in laboratory research. Studies have examined NNMT inhibition in relation to cellular methylation balance, NAD metabolism, and broader metabolic signaling pathways.
In Stock
- Delivery & Return
Delivery
We ship to all address in Canada and all 50 states, Washington DC. All orders are shipped with a Canada Post tracking number. Always free shipping for orders over $500. During sale periods and promotions the delivery time may be longer than normal. Items marked "On-Demand" "Special Order" "On Backorder" are not refundable or eligible for return as they are ordered on a case by case basis.Return
Due to the nature of the products we sell, and for health safety concerns for our valuable customers, our products are non-returnable (sales are final). This policy will be strictly enforced.Help
Give us a shout if you have any other questions and/or concerns. Email:Â sales@mecp.ca Phone: +1 (437) 990-9174 - Ask a Question
5 Amino 1MQ 50MG is a 50-milligram format of 5-amino-1-methylquinolinium (5-amino-1MQ), a quaternary ammonium quinolinium small molecule used in research involving nicotinamide N-methyltransferase (NNMT). Researchers study NNMT and its inhibitors in the context of nicotinamide handling, methyl donor utilization, and metabolic regulation across different model systems.
In published research, 5-amino-1MQ has been used as a chemical tool to probe NNMT-linked pathways, with preclinical studies examining downstream readouts such as changes in methylation-related metabolites and NAD-associated biochemistry. 5 Amino 1MQ 50MG may be useful when a defined-quantity NNMT inhibitor is needed for method development, assay work, or comparative studies.
- Specification: 50MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Tirzepatide 10MG is a 10-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glycemic physiology, and energy balance pathways.
In Stock
Trenbolone Base 50mg ml 10ml refers to trenbolone in a 50 mg per mL concentration across a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from the 19 nor testosterone scaffold. Researchers have used trenbolone as a reference compound in studies involving androgen receptor signaling and anabolic steroid structure activity relationships.
In Stock
Trenbolone Acetate 100Mg; Drostanolone Propionate 100Mg; Testosterone Propionate 100Mg – 300mg/ml, 10ml is a multi compound anabolic androgenic steroid blend specified at 300mg/ml in a 10ml format. Trenbolone acetate is a 19 nor testosterone derivative, while drostanolone and testosterone propionate are DHT derived and testosterone based esters used in androgen research. Researchers may examine combined esterified androgens in models involving receptor binding, anabolic androgenic signaling, and pharmacokinetic comparisons.
In Stock
Cagrilintide 5MG is a 5-milligram format of cagrilintide, a long acting amylin analogue peptide engineered for extended receptor activity. Researchers study amylin analogues in the context of metabolic signaling, appetite regulation pathways, and gastric emptying models.
In Stock
Semaglutide 20MG is a 20 milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is a 31 amino acid peptide modified for extended stability, and it is widely used in laboratory work involving incretin signaling and metabolic regulation. Researchers study semaglutide in preclinical and translational settings related to glucose homeostasis, appetite pathways, and receptor pharmacology.
In Stock
Cagrilintide + Semaglutide 10MG is a 10-milligram peptide pair combining cagrilintide, an amylin analogue, with semaglutide, a GLP-1 receptor agonist peptide. Researchers study these peptides in metabolic research, including appetite signaling and glucose regulation pathways. This paired format is used in experimental designs that examine co-agonism and complementary endocrine signaling.
In Stock
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
Trenbolone Hexahydrobenzyl Carbonate – 100mg/ml, 10ml is a specified format of trenbolone hexahydrobenzyl carbonate, a long ester derivative of trenbolone, a synthetic anabolic androgenic steroid (19 nor testosterone analogue). It is studied analytically in steroid ester profiling, reference standard comparison, and method development using chromatographic and mass spectrometric techniques.
In Stock
Semaglutide 2MG is a 2-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is studied in pharmacology and metabolic research as a long acting incretin mimetic. Researchers examine semaglutide in receptor signaling and glucose homeostasis models.
In Stock
Semaglutide 15MG is a 15-milligram format of semaglutide, a synthetic peptide analogue of the endogenous incretin hormone GLP 1. Researchers study semaglutide as a GLP 1 receptor agonist in models of glucose regulation, appetite signaling, and cardiometabolic physiology.
In Stock
Trenbolone Enanthate 250Mg; Drostanolone Enanthate 250Mg – 500mg/ml, 10ml is a combined format of two anabolic androgenic steroid esters: trenbolone (a 19 nor testosterone derivative) and drostanolone (a DHT derived analogue). Researchers may reference these compounds in studies involving androgen receptor signaling, esterified steroid pharmacokinetics, and analytical method development. Work in the literature commonly discusses trenbolone and drostanolone in the context of endocrine pathways and structure activity relationships.
In Stock


